Font Size: a A A
Keyword [pharmacoeconomic evaluation]
Result: 21 - 40 | Page: 2 of 2
21. Medication Using Evaluation Of Carbapenems
22. Pharmacoeconomic Evaluation Of Yiqifumai(Lyophilization) Injection Versus Xinmailong Injection In The Treatment Of Chronic Heart Failure
23. Effect Analysis And Pharmacoeconomic Evaluation On Lithium Combined With Second Generation Antipsychotics In Patients With Bipolar Disorder Manic Episode
24. Cost Effectiveness Analysis Of New Pharmacoeconomic Evaluation Method Based On Bayesian Inference For The Treatment Of Chronic Obstructive Pulmonary Disease
25. Pharmacoeconomic Evaluation Of Camrelizumab Plus Chemotherapy In First-line Treatment Of Advanced Non-squamous Non-small-cell Lung Cancer
26. Methodological Research On Pharmacoeconomic Evaluation Of Gastrointestinal Cancer Based On RWD
27. The Clinical Evaluation Of Warfarin And Its Pharmacoeconomic Evaluation With Rivaroxaban
28. Pharmacoeconomic Evaluation Of Rosuvastatin In Primary Prevention Of Cardiovascular Disease
29. Clinical Research And Pharmacoeconomic Evaluation Of Huoxue Huatan Xifeng Decoction For Patients With Acute Cerebral Infarctio (With The Syndrome Of Wind-phlegm Stasis)
30. Pharmacoeconomic Evaluation Of Decompensated Chronic Hepatitis B Fibrosis Based On Net Benefit Regression Framework
31. Pharmacoeconomic Evaluation Of Immunotherapy Combined With Chemotherapy For Lung Cancer And Esophageal Carcinoma
32. Pharmacoeconomic Evaluation Of Hypertension Drugs Based On Markov Model
33. Clinical Pharmacoeconomic Evaluation Of Levosimendan And Milrinone In The Treatment Of Severe Heart Failure
34. The Standardization For Health State Utility Values Applied In Pharmacoeconomic Evaluation Models
35. Pharmacoeconomic Evaluation Of DNF-N Vs. DPF-P In The Treatment Of Locally Advanced Nasopharyngeal Carcinoma By Markov Model
36. Therapeutic Efficacy And Pharmacoeconomic Evaluation Of Budesonide Formoterol,Salmeterol Ticasone And Tiotropium Bromide In Patients With Acute Exacerbation Of COPD
37. Pharmacoeconomic Evaluation On Dapagliflozin In Patients With Type 2 Diabetes And Cardiovascular Disease
38. Pharmacoeconomic Evaluation Of Empagliflozin In The Treatment Of Heart Failure With Reduced Ejection Fraction
39. Pharmacoeconomic Evaluation Of Carfilzomib In The Treatment Of Newly Diagnosed Multiple Myeloma
40. Pharmacoeconomic Evaluation Of Brucea Javanica Injection Combined With First-line Chemotherapy For Postoperative Treatment Of Colorectal Cancer
  <<First  <Prev  Next>  Last>>  Jump to